Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(33%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
4
44%
Ph phase_1
5
56%

Phase Distribution

5

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
5(55.6%)
Phase 3Large-scale testing
4(44.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(5)

Detailed Status

Completed5
Active, not recruiting2
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (55.6%)
Phase 34 (44.4%)

Trials by Status

completed556%
active_not_recruiting222%
enrolling_by_invitation111%
recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9